Integrated Bioinformatics Analysis: Sepsis and AMI Hub Genes

Integrated bioinformatics analysis reveals cross-talking hub genes and therapeutic agents between sepsis and acute myocardial infarction. The dataset likely contains results from differential gene expression analysis, weighted gene co-expression network analysis, and protein-protein interaction networks. It includes validation data from qPCR and molecular docking simulations for potential therapeutic compounds.

Use Cases

• Identifying potential therapeutic targets based on common hub genes JAK2, MYD88, and TIMP1.
• Evaluating diagnostic performance of biomarkers via receiver operating characteristic curve analysis.
• Analyzing immune cell infiltration patterns correlated with core gene expression.
• Performing molecular docking simulations to assess drug candidate binding affinity, such as quercetin.
• Validating gene expression findings with qPCR data from patient samples.

Strengths

• Identifies 417 common genes between sepsis and acute myocardial infarction.
• Includes functional enrichment analyses (GO and KEGG) and validation via qPCR.
• Provides molecular docking results for a specific therapeutic compound (quercetin).

Limitations

• Column names and row count are unknown, limiting understanding of data structure.
• The dataset's size (5516316) is provided, but its meaning (bytes, rows, etc.) is unclear.
• The primary data source for AMI is the GEO database, but specific accession numbers are not listed.

Provenance

Source

AMI data from GEO database; sepsis RNA-seq data from hospital blood samples.

Collection Method

Differential expression gene analysis, weighted gene co-expression network analysis, protein-protein interaction network construction.

Freshness

Last updated on 2026-03-21.